Akanda Corp. (AKAN) vs IM Cannabis Corp. (IMCC)

Akanda Corp. and IM Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $2.4M against $2.0M — 1.3× the size. Across the 9 metrics below, Akanda Corp. leads on 7 and IM Cannabis Corp. on 2.

Valuation

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S n/m 0.03 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.02 2.56
Earnings yield — (2,710.65%) (2.99%)
Free cash flow yield 0.00% (55.53%) 0.00%

Profitability

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Gross margin — 12.62% 53.94%
Operating margin — (32.88%) 0.00%
Net margin — (38.92%) 0.00%
Free cash flow margin 0.00% (1.47%) 0.00%
Return on equity 0.00% 2,280.06% (0.40%)
Return on assets 0.00% (54.20%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (11.97%) 10.01%
EPS growth (last fiscal year) (139.63%) 41.95% —
Revenue growth, 5-year CAGR 44.20% 26.99% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) (0.12) 0.05
Current ratio 0.58 0.56 2.31
Net debt to EBITDA (2.75) 0.18 0.85

Dividend

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN IMCC Drug Manufacturers Specialty & Generic median
Market cap 2.44m 1.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack